Polypharmacy Management in Elderly Patients with Multimorbidity

doi:10.12114/j.issn.1007-9572.2022.00.009

Chinese General Practice ›› 2022, Vol. 25 ›› Issue (13): 1545-1550.DOI: 10.12114/j.issn.1007-9572.2022.00.009

Special Issue: 老年人群健康最新文章合辑；用药最新文章合辑；老年人合理用药专题研究；共病最新文章合辑；老年问题最新文章合辑

• Rational Drug Use in the Elderly • Previous Articles Next Articles

Polypharmacy Management in Elderly Patients with Multimorbidity

1. School of Nursing and Health, Zhengzhou University, Zhengzhou 450001, China
2. Department of Endocrinology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China
3. Teaching and Research Department, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China

Received:2021-09-06 Revised:2021-11-22 Published:2022-05-05 Online:2022-04-22
Contact: Chunhui ZHANG
About author:
PAN W Y, ZHANG C H, ZHANG Z X, et al. Polypharmacy management in elderly patients with multimorbidity[J]. Chinese General Practice, 2022, 25 (13) : 1545-1550.

老年慢性病共病患者多重用药管理分析与评论

1．450001　河南省郑州市，郑州大学护理与健康学院
2．450014　河南省郑州市，郑州大学第二附属医院内分泌科
3．450014　河南省郑州市，郑州大学第二附属医院教研室

通讯作者: 张春慧
作者简介:
潘婉玉，张春慧，张振香，等.老年慢性病共病患者多重用药管理分析与评论[J].中国全科医学，2022，25（13）：1545-1550.[www.chinagp.net] 作者贡献：潘婉玉、林蓓蕾负责文章的构思与设计；张振香、梅永霞负责文章的可行性分析；陈静、王少阳负责文献/资料收集；潘婉玉、张春慧负责文献/资料整理；潘婉玉负责论文撰写；张春慧、翟清华负责论文的修订；潘婉玉、张振香负责文章的质量控制及审校；张春慧对文章整体负责，监督管理。
基金资助:
2020年河南省哲学社会科学规划年度项目(2020BSH015); 河南省社发领域科技攻关项目(182102310198)

1. .pdf(476KB)

Abstract

Abstract:

Active implementation of patient-centered polypharmacy management for older adults with multimorbidity can help to identify and correct the medication errors that patients may have, avoid the occurrence of potential medication errors, reduce and control the development of drug-related diseases, improve the clinical treatment effect, and delay the disease progression, thereby facilitating the achievement of targets for disease control, and improvement of quality of life of patients. In the light of problems of polypharmacy in Chinese elderly patients with multimorbidity, we summarized relevant interventions including strengthening top-level design of management, building multidisciplinary teams, innovating medication management technologies, and meeting patients'needs of drug information, providing a reference for medication management of these patients. We found that problems of polypharmacy in Chinese elderly patients are serious, and actively exploring multiple approaches to polypharmacy management based on medication features of these patients may be a key breakthrough for addressing the problems.

Key words: Elderly, Multimorbidity, Medication management, Analysis and comment

摘要：

积极落实以老年慢性病共病患者为中心的多重用药管理策略，能够识别和纠正老年慢性病共病患者的用药差错，避免潜在用药错误的发生，减少并控制药源性疾病的发生与发展，进而有助于提高疾病临床治疗效果，延缓疾病发展进程，从而有利于疾病控制达标，提高老年慢性病共病患者的生活质量。本研究针对老年慢性病共病患者存在的多重用药问题，从强化顶层设计、组建老年多学科团队、革新患者药物管理产品技术、满足患者对药物信息的需求等方面对干预措施进行总结，旨在为今后我国老年慢性病共病患者的用药管理提供参考。本研究发现，老年慢性病共病患者多重用药问题突出。基于老年人的用药特点，积极探索多途径的多重用药管理策略是目前改善老年慢性病共病患者多重用药问题的重要突破点。

关键词: 老年人, 慢性病共病, 用药管理, 分析与评论

Wanyu PAN,Chunhui ZHANG,Zhenxiang ZHANG, et al. Polypharmacy Management in Elderly Patients with Multimorbidity[J]. Chinese General Practice, 2022, 25(13): 1545-1550. DOI: 10.12114/j.issn.1007-9572.2022.00.009.
潘婉玉,张春慧,张振香等. 老年慢性病共病患者多重用药管理分析与评论[J]. 中国全科医学, 2022, 25(13): 1545-1550. DOI: 10.12114/j.issn.1007-9572.2022.00.009.

References 18

[1]	WHO. Global health risks：mortality and burden of disease attributable to selected major risks[EB/OL].(2019-09-10)[2020-12-20].
[2]	TINETTI M E, STUDENSKI S A. Comparative effectiveness research and patients with multiple chronic conditions[J]. N Engl J Med，2011，364(26):2478-2481. DOI：10.1056/NEJMp1100535.
[3]	BAHLER C, HUBER C A, BRUNGGER B，et al. Multimorbidity，health care utilization and costs in an elderly community dwelling population：a claims data based observational study[J]. BMC Health Serv Res，2015，15(1):23. DOI：10.1186/s12913-015-0698-2.
[4]	崔娟，毛凡，王志会.中国老年居民多种慢性病共存状况分析[J].中国公共卫生，2016，32(1):66-69. DOI：10.1847/zggws2016-32-01-20.
[5]	HUON J F, LENAIN E, LEGUEN J，et al. How drug use by French elderly patients has changed during the last decade[J].Drugs Real World Outcomes，2015，2(4):327-333. DOI：10.1007/s40801-015-0041-6.
[6]	World Health Organization. Medication safety in polypharmacy[EB/OL].(2019-09-20)[2020-12-20].
[7]	CHARLESWORTH C J, SMIT E, LEE D S H，et al. Polypharmacy among adults aged 65 years and older in the United States：1988—2010[J]. J Gerontol A Biol Sci Med Sc，2015，70(8):989-995. DOI：10.1093/gerona/glv013.
[8]	金福碧，郑和昕，林玲萍，等. 老年住院患者多重用药调查分析与对策[J].浙江中医药大学学报，2012，36(12):1360-1363. DOI：10.16466/j.issn1005-5509.2012.12.026.
[9]	冯娇，吕广梅. 南京市江浦街道老年人用药情况调研[J].中国卫生产业，2016，13(12):167-169. DOI：10.16659/j.cnki.1672-5654.2016.12.167.
[10]	赖小星，朱宏伟，霍晓鹏，等. 老年多重用药患者用药依从性现状及其影响因素的研究[J]. 中国护理管理，2016，16(12):1638-1642. DOI：10.3969/j.issn.1672-1756.2016.12.012.
[11]	HELD F P, BLYTH F, GNJIDIC D，et al. Association rules analysis of comorbidity and multimorbidity：the concord health and aging in men project[J]．J Gerontol A Biol Sci Med Sci，2016，71(5):625-631. DOI：10.1093/gerona/glv181.
[12]	SPINEWINE A, SCHMADER K E, BARBER N，et al. Appropriate prescribing in elderly people：how well can it be measured and optimized[J]. Lancet，2007，370(9593):173-184. DOI：10.1016/S0140-6736(07)61091-5.
[13]	张海霞，陈晓，刘金春，等. 某院老年住院患者潜在不适当用药情况[J]. 医药导报，2018，37(8):1004-1008. DOI：10.3870/j.issn.1004-0781.2018.08.018.
[14]	HYTTINEN V, JYRKKÄ J, SAASTAMOINEN L K，et al. The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons：a longitudinal 12-year study[J]. Eur J Health Econ，2019，20(2):233-243. DOI：10.1007/s10198-018-0992-0.
[15]	GARCIA R M. Five ways you can reduce inappropriate prescribing in the elderly：a systematic review[J]. J Fam Pract，2006，55(4):305-312.
[16]	SIMOES P A, SANTIAGO L M, MAURCIO K，et al. Prevalence of potentially inappropriate medication in the older adult population within primary care in Portugal：a nationwide cross-sectional study[J]. Patient Prefer Adher，2019，19(13):1569-1576. DOI：10.2147/PPA.S219346.eCollection2019.
[17]	孙艳萍，王烨，邢玉晶，等. 门诊老年患者潜在不适当用药情况调查及影响因素分析[J]. 中国新药杂志，2018，27(16):1939-1944.
[18]	曲国红，智俊娜，陈龙保，等.老年患者多重用药风险及其影响因素分析[J]. 药学与临床研究，2020，28(5):363-366. DOI：10.13664/j.cnki.pcr.2020.05.010.

Polypharmacy Management in Elderly Patients with Multimorbidity

老年慢性病共病患者多重用药管理分析与评论

RichHTML

PDF

Supplement

Knowledge

Abstract

Cite this article

share this article

References 18

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778.
[2]	CHENG Yuxin, FANG Jiamin, LIANG Hao, WANG Zhiling, WEI Li, LIAO Huilian, XU Mingming, CHEN Yumei, LI Yanfen, DONG Lijuan, GUO Yingui. Preoperative Platelet-to-albumin Ratio in Elective Geriatric Surgery Patients and Its Correlation with Postoperative Incidental Frailty: a Multicenter Study [J]. Chinese General Practice, 2025, 28(27): 3359-3367.
[3]	YAN Fanghong, PENG Guotian, ZHANG Guoli, SUN Ruiyi, MA Yuxia, HAN Lin. Matching Analysis of the Content of Chronic Disease Management for the Elderly in Medical Union: Based on the Perspective of "Guidance-Practice-Need" [J]. Chinese General Practice, 2025, 28(25): 3119-3126.
[4]	LONG Chunxiao, LI Chenglu, FAN Yangdong, SHI Lei. Quantitative Analysis of Chronic Disease Prevention and Treatment Policy Texts in China: Three-dimensional Framework Based on Policy Tools, Policy Evolution and Policy Subjects [J]. Chinese General Practice, 2025, 28(20): 2457-2463.
[5]	GUO Yi, HAN Xuanye, LIU Zhaojun, JIANG Yaoyao, FU Yang, SHI Lei, ZHAO Shihong. Construction of a Medical Transition Intervention Model for Multiple Chronic Diseases in Children Based on the E-Coach Management Model [J]. Chinese General Practice, 2025, 28(20): 2530-2537.
[6]	FANG Yingying, LIN Weiquan, SUN Minying, LI Yaohui, LIU Lan, YANG Yunou, CHEN Jiamin, LUO Liying, SHI Lei, LIU Hui. Influence of Screen Time on Sleep Quality among Patients with Multimorbidity Aged 35 and Above [J]. Chinese General Practice, 2025, 28(20): 2501-2507.
[7]	PAN Yaojia, FU Fanglin, HAN Zheng, SUN Meng, GU Huaicong, WANG Weiqiang. Correlation of the Type of Obesity with the Cardiometabolic Multimorbidity: a Study in Male and Female Middle-aged Residents in Anhui Province [J]. Chinese General Practice, 2025, 28(18): 2285-2293.
[8]	HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang. A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above [J]. Chinese General Practice, 2025, 28(18): 2278-2284.
[9]	CHEN Qiaoqiao, SU Ping, ZHAO Yingying, PANG Jinhong, SHI Jie, WANG Yaqian, LI Qiuchun, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association between Triglyceride-Glucose Index and Incident Cardiometabolic Multimorbidity in the Elderly: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(18): 2270-2277.
[10]	ZHAO Can, SHEN Ying, XI Qian, PENG Houxuan, QIN Jinqiong, WANG Xuan, ZHENG Yanping, QIN Li, ZUO Yanli. The Hospitalization Spending and Associated Factors in Inpatients with Multimorbidity in Township Health Centers in Guangxi [J]. Chinese General Practice, 2025, 28(16): 2039-2049.
[11]	WEI Xuan, WANG Ning, WEI Ying, CHEN Qilin, ZHAO Yang. Analysis of Depression Status and Influencing Factors in Middle-aged and Elderly Patients with Chronic Diseases in China: an Empirical Analysis Based on CHARLS Data [J]. Chinese General Practice, 2025, 28(11): 1303-1308.
[12]	FAN Jianing, CHEN Jieting, WANG Ziqi, FAN Jinhe, JING Mingxia. Analysis of the Development Trajectory of Health-related Quality of Life in Middle-aged and Elderly Patients with Cardiometabolic Diseases and the Influencing Factors [J]. Chinese General Practice, 2025, 28(08): 923-932.
[13]	LUO Yuan, ZHANG Hua, WANG Sanxiang, ZHANG Mengxi, DENG Yuqian, RAN Haiye, LIU Jiaxin, ZHANG Yi, CHEN Xi, WU Yibo, ZHAO Liping. Development of a Comprehensive Fall Risk Assessment Tool for Older People in Elderly Care Institutions and Its Test [J]. Chinese General Practice, 2025, 28(04): 491-498.
[14]	XIN Bo, WU Yixin, ZHANG Di, HE Yuxin, YANG Shan, LI Mengchi, JIANG Wenhui. Advances in Cognitive Impairment in the Multimorbidity [J]. Chinese General Practice, 2025, 28(02): 143-148.
[15]	QIN Wei, TU Gangying, WAN Xiaomei, WANG Fang. Effects of Balance-strengthening Training on Balance Ability in Elderly Inpatients with Schizophrenia: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(02): 193-199.